Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2022-11-10 Sale | 2022-11-14 4:51 pm | Aclaris Therapeutics Inc. | ACRS | SCHIFF ANDREW N Director | 53,926 | $17.05 | $919,589 | 434,455 (Indirect Direct) | View |
| 2022-10-24 Sale | 2022-10-26 7:09 pm | Aclaris Therapeutics Inc. | ACRS | SCHIFF ANDREW N Director | 41,174 | $17.01 | $700,355 | 488,381 (Indirect Direct) | View |
| 2022-10-17 Sale | 2022-10-19 4:49 pm | Aclaris Therapeutics Inc. | ACRS | SCHIFF ANDREW N Director | 52,037 | $16.57 | $862,109 | 529,555 (Indirect Direct) | View |
| 2022-10-07 Sale | 2022-10-11 4:35 pm | Aclaris Therapeutics Inc. | ACRS | SCHIFF ANDREW N Director | 7,324 | $16.16 | $118,349 | 581,592 (Indirect Direct) | View |
| 2022-10-04 Sale | 2022-10-06 5:58 pm | Aclaris Therapeutics Inc. | ACRS | SCHIFF ANDREW N Director | 45,539 | $16.45 | $749,002 | 588,916 (Indirect Direct) | View |
| 2022-06-17 Sale | 2022-06-21 4:57 pm | Aclaris Therapeutics Inc. | ACRS | SCHIFF ANDREW N Director | 19,565 | $15.14 | $296,269 | 634,455 (Indirect Direct) | View |
| 2021-06-29 Purchase | 2021-07-01 6:29 pm | Elevation Oncology Inc. | ELEV | Aisling Capital IV LP Aisling Capital Partners IV LLC Aisling Capital Partners IV LP ELMS STEVE SCHIFF ANDREW N 10% Owner | 187,500 | $16 | $3,000,000 | 2,834,910 (Direct) | View |
| 2019-07-15 Purchase | 2019-07-15 4:15 pm | SUNESIS PHARMACEUTICALS INC | SNSS | Aisling Capital IV LP Aisling Capital Partners IV LLC Aisling Capital Partners IV LP SCHIFF ANDREW N ELMS STEVE 10% Owner | 2,500,000 | $0.6 | $1,500,000 | 10,100,000 (Indirect) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2023-06-16 Option Award | 2023-06-21 4:09 pm | N/A 2033-06-15 | Elevation Oncology Inc. | ELEV | Aisling Capital IV LP Aisling Capital Partners IV LLC Aisling Capital Partners IV LP ELMS STEVE SCHIFF ANDREW N 10% Owner | 31,238 | $0 | 31,238 (Indirect) | View |
| 2023-06-14 Option Award | 2023-06-15 4:28 pm | N/A 2033-06-13 | Monte Rosa Therapeutics Inc. | GLUE | SCHIFF ANDREW N Director | 20,500 | $0 | 20,500 (Direct) | View |
| 2023-06-02 Exercise | 2023-06-05 4:53 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | SCHIFF ANDREW N Director | 4,507 | $0 | 459,372 (Direct) | View |
| 2023-06-01 Option Award | 2023-06-05 4:53 pm | N/A 2033-05-31 | Aclaris Therapeutics Inc. | ACRS | SCHIFF ANDREW N Director | 20,410 | $0 | 459,372 (Direct) | View |
| 2022-06-17 Option Award | 2022-06-22 6:43 pm | N/A 2032-06-16 | Elevation Oncology Inc. | ELEV | Aisling Capital IV LP Aisling Capital Partners IV LLC Aisling Capital Partners IV LP ELMS STEVE SCHIFF ANDREW N 10% Owner | 15,619 | $0 | 15,619 (Indirect) | View |
| 2022-06-15 Option Award | 2022-06-16 4:31 pm | N/A 2032-06-14 | Monte Rosa Therapeutics Inc. | GLUE | SCHIFF ANDREW N Director | 15,000 | $0 | 15,000 (Direct) | View |
| 2022-06-03 Exercise | 2022-06-06 5:36 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | SCHIFF ANDREW N Director | 3,356 | $0 | 674,277 (Direct) | View |
| 2022-06-02 Option Award | 2022-06-06 5:36 pm | N/A 2032-06-01 | Aclaris Therapeutics Inc. | ACRS | SCHIFF ANDREW N Director | 20,257 | $0 | 674,277 (Direct) | View |
| 2021-06-29 Conversion | 2021-07-01 6:29 pm | N/A N/A | Elevation Oncology Inc. | ELEV | Aisling Capital IV LP Aisling Capital Partners IV LLC Aisling Capital Partners IV LP ELMS STEVE SCHIFF ANDREW N 10% Owner | 12,288,426 | $0 | 2,834,910 (Direct) | View |
| 2021-06-24 Option Award | 2021-06-28 6:18 pm | N/A 2031-06-23 | Elevation Oncology Inc. | ELEV | Aisling Capital IV LP Aisling Capital Partners IV LLC Aisling Capital Partners IV LP ELMS STEVE SCHIFF ANDREW N 10% Owner | 31,238 | $0 | 31,238 (Indirect) | View |
| 2021-06-23 Option Award | 2021-06-25 5:01 pm | N/A 2031-06-22 | Monte Rosa Therapeutics Inc. | GLUE | SCHIFF ANDREW N Director | 47,132 | $0 | 47,132 (Direct) | View |
Ownership | 2021-06-24 6:32 pm | N/A N/A | Elevation Oncology Inc. | ELEV | Aisling Capital IV LP ELMS STEVE Aisling Capital Partners IV LLC Aisling Capital Partners IV LP SCHIFF ANDREW N 10% Owner | 0 | $0 | 2,647,410 (Direct) | View |
| 2021-06-03 Option Award | 2021-06-04 8:12 pm | N/A 2031-06-02 | Aclaris Therapeutics Inc. | ACRS | SCHIFF ANDREW N Director | 15,606 | $0 | 15,606 (Direct) | View |
| 2020-06-06 Exercise | 2020-06-08 5:27 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | SCHIFF ANDREW N Director | 7,333 | $0 | 667,164 (Direct) | View |
| 2020-06-04 Option Award | 2020-06-08 5:27 pm | N/A 2030-06-03 | Aclaris Therapeutics Inc. | ACRS | SCHIFF ANDREW N Director | 16,500 | $0 | 667,164 (Direct) | View |
| 2020-03-02 Exercise | 2020-03-04 4:28 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | SCHIFF ANDREW N Director | 8,876 | $0 | 652,207 (Direct) | View |
| 2020-03-02 Option Award | 2020-03-04 4:28 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | SCHIFF ANDREW N Director | 8,876 | $0 | 652,207 (Direct) | View |
| 2019-12-02 Option Award | 2019-12-06 10:23 am | N/A N/A | Zosano Pharma Corp | ZSAN | Aisling Capital IV LP Aisling Capital Partners IV LP Aisling Capital Partners IV LLC ELMS STEVE SCHIFF ANDREW N 10% Owner | 689,655 | $1.45 | 2,718,226 (Direct) | View |
| 2019-06-06 Option Award | 2019-06-10 4:49 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | SCHIFF ANDREW N Director | 7,333 | $0 | 7,333 (Direct) | View |